- £67.71bn
- £81.07bn
- £30.33bn
- 86
- 47
- 80
- 85
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33,754 | 24,354 | 24,696 | 29,324 | 30,328 |
Cost of Revenue | |||||
Gross Profit | 23,586 | 17,033 | 16,690 | 20,857 | 21,965 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 26,793 | 18,375 | 20,375 | 22,891 | 23,582 |
Operating Profit | 6,961 | 5,979 | 4,321 | 6,433 | 6,746 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6,221 | 5,170 | 3,599 | 5,628 | 6,064 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,268 | 5,103 | 3,516 | 4,921 | 5,308 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4,645 | 5,749 | 4,385 | 14,956 | 4,928 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,645 | 5,749 | 4,385 | 14,956 | 4,928 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.69 | 0.789 | 0.681 | 1.14 | 1.4 |
Dividends per Share |